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ABSTRACT 
EFSA´s scientific Panel on Biological Hazards (BIOHAZ Panel) provides independent scientific advice on 
biological hazards in relation to food safety and food-borne diseases. This covers food-borne zoonoses, food 
microbiology, food hygiene, antimicrobial resistance (AMR), transmissible spongiform encephalopathies 
(BSE/TSEs) and associated waste management issues. Most of the activities of the BIOHAZ Panel focus on 
human health and the whole food chain and on science-based interventions to lower the risk to consumers. In the 
future, food-borne disease burden estimations are foreseen to become increasingly relevant. The risk assessments 
done by the BIOHAZ Panel are in line with the EU (European Union) strategy of one health, include a farm to 
fork approach and in many cases have a high multidisciplinary component. Whenever possible, the Panel applies 
this risk assessment framework developed by Codex Alimentarius as a basis for their work on food safety. The 
outcomes of some of the activities during the last three to four years are presented. From these examples of 
recent BIOHAZ opinions it can be seen that the work covers different approaches, ranging from quantitative risk 
assessments over structured qualitative risk assessment/risk ranking to opinions with short deadlines 
summarising existence knowledge from scientific literature. The approach taken depends on both the terms of 
reference (ToR) as received from the EC (European Commission), the available data and resources, and last but 
not least the time frame for the work following the risk managers’ needs. 
© European Food Safety Authority, 2012 
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INTRODUCTION 
Food safety needs to be controlled in an integrated longitudinally farm to fork approach. In the 1980’s 
the main focus was on using good hygiene practices, in the 90’s the HACCP (Hazard Analysis Critical 
Control Point) concept was implemented, and in the 2000’s the Risk analysis framework developed by 
the Codex Alimentarius Commission (CAC) in the 90’s has started being implemented at the EU level.  
In the European Union, both EC and EFSA use this risk analysis framework as basis for their work on 
food safety. EFSA´s scientific Panel on Biological Hazards (BIOHAZ Panel) provides independent 
scientific advice on biological hazards in relation to food safety and food-borne diseases. This covers 
food-borne zoonoses, food microbiology, food hygiene, antimicrobial resistance (AMR), transmissible 
spongiform encephalopathies (BSE/TSEs) and associated waste management issues. Most of the 
activities of the BIOHAZ Panel focus on human health and the whole food chain and on science-based 
interventions to lower the risk to consumers. In the future, food-borne disease burden estimations are 
foreseen to become increasingly relevant. 
The BIOHAZ Panel addresses mandates related to general risk assessments (qualitative and 
quantitative) of food-borne pathogens in different animal population and food commodities. Providing 
scientific advice on food hygiene and food-borne zoonoses including antimicrobial resistance issues 
constitutes one of the main areas of work, and during the latest mandate of the Panel (2009-2012), 33 
opinions on these subjects have been adopted.  
The BIOHAZ Panel also assesses applications related to alternative treatments for disposal of different 
categories of Animal By-Products (ABP), TSE diagnostic tests and on the efficacy and possible 
development of AMR of treatments for the decontamination of food of animal origin. In this area, the 
Panel in the above period has produced 21 assessments plus 3 opinions on guidance for applicants. 
Moreover, an annual task of the BIOHAZ Panel is to produce a list of microorganisms that have a 
Qualified Presumption of Safety (QPS) as an EFSA tool for simplifying risk assessments concerning 
the safety of microorganisms, mostly in the area of feed additives by the Panel on Additives and 
Products or Substances used in Animal Feed (FEEDAP Panel). 
In the area of TSEs, the BIOHAZ Panel has played a key role in providing scientific advice to risk 
managers allowing the adaptation of the EU regulations following the evolution of the epidemiological 
situation and according to the EU TSE Road Maps 2005 and 2010. In the period from March 2009 to 
June 2012, 20 Scientific Opinions, 3 Technical Reports and one Statement on TSEs have been 
adopted. 
It is important to highlight that the risk assessments done by the BIOHAZ Panel in line with the EU 
strategy of one health
3
 include a farm to fork approach, and in many cases they have a high 
multidisciplinary component. As a consequence, the BIOHAZ Panel works in some cases in close 
collaboration with sister agencies in the EU public health area such as the European Medicines 
Agency (EMA) and the European Centre for Disease Control (ECDC), the EC non-food Scientific 
Committees (SCHER and SCENIHR) and last but not least with other EFSA Scientific Panels such as 
the Panel on Animal Health and Welfare (AHAW), the Panel on Contaminants (CONTAM), the Panel 
on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) and the Genetically 
Modified Organisms (GMO) Panel. 
In this paper we briefly describe the outcome of some of our activities during the period 2009-2012. 
  
                                                     
3  Available from http://ec.europa.eu/food/dyna/conference/ 
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1. QUANTITATIVE MICROBIOLOGICAL RISK ASSESSMENT OF FOOD-BORNE ZOONOSES 
Quantitative Microbiological Risk Assessment (QMRA) of food-borne pathogens at European level 
has proven a useful tool to enable risk managers to evaluate the feasibility and the cost-benefit ratio of 
introducing control measures and targets to further protect the public health of European consumers. 
QMRAs have been used by the BIOHAZ Panel to support Scientific Opinions and to better reply to 
the questions asked by the risk managers to further protect consumers from food risks. Examples are: 
Quantitative estimation of the impact of setting a new target for the reduction of Salmonella in 
breeding hens of Gallus gallus (EFSA, 2009a), Salmonella in slaughter and breeding pigs (EFSA 
Panel on Biological Hazards (BIOHAZ), 2010b), Salmonella in laying hens and broilers (EFSA Panel 
on Biological Hazards (BIOHAZ), 2010a, 2011a), and Campylobacter in broilers (EFSA Panel on 
Biological Hazards (BIOHAZ), 2011b).  
In 2011, a QMRA model was developed and used in the framework of the Scientific Opinion on a 
QMRA of Campylobacter in broiler meat to determine the effect of interventions from farm to fork on 
the incidence of human campylobacteriosis. Reductions to the public health risk of campylobacteriosis 
could be achieved through a variety of interventions, both in primary production or at the 
slaughterhouse, with different impacts. Reductions of public health risk using targets at primary 
production or microbiological criteria were also estimated through modelling using additional models.  
In the opinion several different control options were assessed in relation to their efficacy of reducing 
the public health risk from Campylobacter in broiler meat. Thus it was estimated that there are 
approximately nine million cases of human campylobacteriosis per year in the EU27. The disease 
burden of campylobacteriosis and its sequelae is 0.35 million disability-adjusted life years (DALYs) 
per year and the total annual costs are 2.4 billion Euros. Broiler meat may account for 20 % to 30 % of 
these, while 50 % to 80 % may be attributed to the chicken reservoir as a whole (broilers as well as 
laying hens). The public health benefits of controlling Campylobacter in primary broiler production 
are expected to be greater than control later in the chain as the bacteria may also spread from farms to 
humans by other pathways than broiler meat. 
Strict implementation of biosecurity in primary production and GMP/HACCP during slaughter may 
reduce colonisation of broilers with Campylobacter, and contamination of carcasses. After slaughter, a 
100 % risk reduction can be reached by irradiation or cooking of broiler meat on an industrial scale. 
More than 90 % risk reduction can be obtained by freezing carcasses for 2-3 weeks. A 50-90 % risk 
reduction can be achieved by freezing for 2-3 days, hot water or chemical carcass decontamination. 
Achieving a target of 25 % or 5 % between flock prevalence (BFP) in all Member States (and 
assuming that those with lower BFP keep this) is estimated to result in 50 % and 90 % reduction of 
public health risk, respectively. A public health risk reduction > 50 % or > 90 % could be achieved if 
all batches would comply with a microbiological criteria with a critical limit of 1 000 or 500 CFU 
(colony forming units)/gram of neck and breast skin, respectively, while 15 % and 45 % of all tested 
batches would not comply with these criteria. 
The risk assessment has provided valuable information to the EC and enables the risk managers to 
make decisions on the most cost-effective risk management options. 
2. ANTIMICROBIAL RESISTANCE 
The BIOHAZ Panel has addressed several issues related to antimicrobial resistance like assessment of 
the public health significance of methicillin resistant Staphyloccus aureus (MRSA) in animals and 
foods (EFSA, 2009b), Joint opinion on antimicrobial resistance (AMR) focused on zoonotic infections 
(EFSA Panel on Biological Hazards (BIOHAZ), 2009), and more recently a scientific opinion on the 
public health risks of bacterial strains producing extended-spectrum β-lactamases (ESBL) and/or 
AmpC β-lactamases in food and food-producing animals (EFSA Panel on Biological Hazards 
(BIOHAZ), 2011d). In this latter opinion it is concluded that there are no data on the comparative 
efficiency of individual control options in reducing public health risks caused by ESBL and/or AmpC-
producing bacteria related to food-producing animals. Prioritisation is complex, but it is considered 
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that a highly effective control option would be to stop all uses of cephalosporins/systemically active 
3
rd
/4
th
 generation cephalosporins, or to restrict their use (use only allowed under specific 
circumstances). As co-resistance is an important issue, it is also of high priority to decrease the total 
antimicrobial use in animal production in the EU. 
3. GUIDANCE DOCUMENTS AND EFFICACY EVALUATION 
Article 3(2) of Regulation (EC) No 853/2004 of the European Parliament and Council
4
, which lays 
down specific hygiene rules for food of animal origin, constitutes the legal basis for the use of 
substances other than potable water or clean water to remove surface contamination from foods of 
animal origin intended for human consumption. The use of such substances can only be considered if 
their toxicological safety and efficacy can be demonstrated. Therefore a joint AFC (EFSA Panel on 
Food Additives, Flavourings, Processing Aids and Materials in Contact with Food )/BIOHAZ draft 
guidance document for the submission of data for the evaluation of the safety and the efficacy of 
substances intended to be used to remove microbial surface contamination of food of animal origin, 
was developed (EFSA, 2006). In 2010 the BIOHAZ Panel of EFSA revised the joint AFC/BIOHAZ 
guidance document (EFSA Panel on Biological Hazards (BIOHAZ), 2010c). This guidance requires 
data and information about the safety and efficacy of the substances, as well as examples of study 
designs at the laboratory and at the slaughterhouse in order to demonstrate these attributes. It also 
includes the factors that should be considered when monitoring the safety and efficacy of a substance 
that has already been authorised and used. 
In addition, all the factors related to the potential occurrence of acquired reduced susceptibility to 
biocides and/or resistance to therapeutic antimicrobials and the issues related to the environmental risk 
due to the use of such substances are considered in this guidance. The evaluation of these aspects is 
divided into pre-market and post-market evaluation. These guidance documents showed very useful in 
the evaluation and efficacy of several decontaminating agents i.e. lactic acid for the removal of 
microbial surface contamination of beef carcasses, cuts and trimmings (EFSA Panel on Biological 
Hazards (BIOHAZ), 2011e), LISTEX P 100 for fish (EFSA Panel on Biological Hazards (BIOHAZ), 
2012c) and Cecure
®
 for Poultry (EFSA Panel on Biological Hazards (BIOHAZ), 2012d) 
4. RISK BASED MEAT INSPECTION  
The BIOHAZ Panel has finalised opinions dealing with meat inspection of swine (EFSA Panel on 
Biological Hazards (BIOHAZ), 2011c) and poultry (EFSA Panel on Biological Hazards (BIOHAZ), 
2012e). The terms of reference for this work was provided by the EC and was, summarised, to identify 
and rank the main risks for public health that should be addressed by meat inspection at EU level, to 
assess the strengths and weaknesses of the current meat inspection, and to recommend new inspection 
and other methods fit for the purpose of meeting the overall objectives of meat inspection. 
The public health related strengths of ante-mortem inspection include inspection of individual 
animals, animal identification, evaluation of animal cleanliness and use of food chain information 
(FCI). However, in current practice, the latter is actually utilised in relation to public health only to a 
limited degree. Since pigs carrying currently most relevant zoonotic agents do not or only very seldom 
show clinical symptoms, the strengths of ante-mortem inspection are mainly related to animal welfare 
and animal health. FCI is insufficiently utilised mainly due to the lack of adequate and harmonized 
indicators that could help risk-classifying the pigs in a public health aspect. Furthermore, the very 
large numbers on animals arriving for slaughter - which are all healthy at first observation - do not 
contribute to opportunities and motivation for proper clinical examination.  
The strengths of post-mortem inspection are mainly related to animal welfare and animal health 
aspects. Classical zoonotic diseases, such as tuberculosis, trichinellosis, and brucellosis, which can be 
detected by post-mortem examination of pigs, have become controlled in many areas where modern 
systems of animal husbandry, disease control and animal health care were introduced. Hence, the 
                                                     
4  Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific 
hygiene rules for on the hygiene of foodstuffs. OJ L 139, 30.4.2004, p. 55–205. 
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ability of current post-mortem meat-inspection to detect lesions caused by e.g. mycobacteria or Taenia 
solium cysticercus (macroscopically) or Trichinella spp. (by specific laboratory methods) is only 
relevant in regions where they are present.  
Currently relevant potential threats to public health associated with slaughtered pigs including agents 
like Salmonella, Y. enterocolitica and Toxoplasma are carried by animals without symptoms, but 
current meat inspection was not designed to detect and/or eliminate these agents. Bacterial species 
isolated from pathological/anatomical abnormalities detected at current post-mortem inspection of pigs 
does not impose a serious health threat to consumers. Nevertheless, finding abscesses is the reason to 
declare the affected meat unfit for human consumption as a meat quality issue and aesthetically 
unacceptable.  
Based on qualitative risk assessment of human pathogenic microorganisms from pig carcasses within 
the EU, Salmonella spp. is considered of high relevance and Yersinia enterocolitica, Toxoplasma 
gondii and Trichinella spp. as of medium relevance. Other hazards are considered of low relevance. 
Because current meat inspection of pigs does not target, and is not able to protect the consumer against 
the most important “new hazards” (Salmonella, Y. enterocolitica, Toxoplasma), appropriate 
procedures for these hazards have to be developed anew. Whilst the current meat inspection targets 
Trichinella, the approach used can be further developed so to be more dynamic and flexible. The 
above ranking relates to the EU as a whole and refinements reflecting differences between regions or 
production systems may be necessary if/where hazard monitoring data indicate. Furthermore, as new 
hazard(s) might emerge and/or hazards that presently are not a priority might become more relevant 
over time or in some regions, the risk ranking is to be revisited regularly. To provide a better evidence 
base for future rankings, studies should be carried out to systematically collect data for source 
attribution and to identify emerging pork-borne hazards, including the collection of more systematic 
data for ranking.  
For poultry meat inspection Campylobacter spp. and Salmonella spp. are considered of high public 
health relevance. Extended-spectrum and AmpC Beta-Lactamase (ESBL/AmpC) gene carrying 
bacteria were considered to be of high to medium (E. coli) and medium (Salmonella) public health 
relevance.  
Effective control of the main hazards in pigs and poultry in the context of meat inspection is possible 
only through a comprehensive pork carcass safety assurance program combining a range of 
preventative measures and controls applied both on-farm and at-abattoir in a longitudinally integrated 
way. A prerequisite for an effective pork carcass safety assurance system is setting of measurable 
targets in respect to the main hazards to be achieved on final, chilled carcasses. These would also 
indicate what has to be achieved at earlier steps in the food chain and focus related control measures.  
On the basis of these opinions the risk managers have now started to draft a new legal framework for a 
modern risk based meat inspection. 
5. BSE/TSE RELATED RISKS 
The favourable evolution both of the bovine spongiform encephalopathy (BSE) and UK variant 
Creutzfeldt-Jakob disease (vCJD) epidemics in recent years – to be well considered as the success 
story of the European response to BSE (Budka, 2011) – changed the scope of TSE-related risk 
questions to EFSA, from more basic risk assessments to evaluation of potential relaxation of costly 
BSE control measures as depicted in the EU TSE Roadmaps. Moreover, recognition of the wide 
diversity of prion strains in the field, including three new forms of animal TSEs (L-type Atypical BSE, 
H-type Atypical BSE and Atypical scrapie), has complicated disease diagnosis and surveillance, as 
well as scientific assessment of the overall TSE risks to humans. 
EFSA and the ECDC delivered a joint scientific opinion on any possible epidemiological or molecular 
association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and 
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ECDC, 2011). That opinion confirmed Classical BSE prions as the only TSE agents demonstrated to 
be zoonotic so far, but the possibility that a small proportion of human cases so far classified as 
“sporadic” CJD might be of zoonotic origin could not be excluded. Moreover, transmission 
experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions 
in cattle [namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy 
(TME) and chronic wasting disease (CWD) agents] might have zoonotic potential. In particular the L-
type Atypical BSE agent might be similar or even more virulent to humans than the Classical BSE 
agent. While mankind has been in contact with small ruminants for millennia, there is no 
epidemiological evidence to suggest that classical scrapie is zoonotic; however, experimental 
transmission data on humanised mice and non-human primates have been very scarce so far. 
Another major field was assessment of the EU-wide tailing of the BSE epidemic as juxtaposed with 
the adequacy of present surveillance measures and a potential revision of the BSE monitoring 
programme. The BIOHAZ Panel confirmed that the BSE epidemic has been declining and is 
converging to the sensitivity limit of a surveillance system that uses currently approved rapid BSE 
tests. It became clear, however, that the stage of the epidemic differed between groups of EU Member 
States. Thus, the country- or group-wise development of the epidemic was assessed by two models 
that provided an estimate of the number of BSE cases that would be missed in Member States under 
several scenarios, including an increase in the current age for BSE testing in the healthy slaughtered 
and at risk cattle testing groups. For some Member States, the BIOHAZ Panel recommended that in 
order to monitor the trend of the Classical BSE epidemic and the trend in the age of the cases 
observed, the results of future testing years should be evaluated. Moreover, it recommended to 
comprehensively reassess the sensitivity of the present or intended new EU surveillance system for 
detecting the prevalence of Atypical BSE, re-emergence of Classical BSE, or the emergence of a novel 
TSE in cattle. 
With regard to present risk mitigation measures, BSE/TSE infectivity was assessed in small ruminant 
tissues. The reduction of the infectivity associated to the carcass of an infected individual achieved by 
the current SRM policy in small ruminants for Classical and Atypical scrapie and BSE was estimated. 
For Classical scrapie, it was concluded that the current specified risk material (SRM) policy allows a 
reduction of the relative infectivity associated to the carcass of an infected animal of about 1 log10. 
When considering BSE in small ruminants, the data available argued against any current widespread 
BSE epidemic within the EU small ruminant population. Because of lack of data, the Panel was not in 
a position to provide an assessment of the current atypical scrapie infectious load entering into the 
food chain. 
Another important area for BIOHAZ risk assessments is treatment of animal waste and by-products. 
With regard to BSE/TSE-related risks, opinions were given on topics as diverse as composting on-
farm of dead poultry; on-site treatment of pig carcasses; isolation in proofed pit on-farm of dead 
poultry; oleochemical processes to minimise TSE risks in Cat. 1 ABP; and revision of the quantitative 
risk assessment (QRA) of the BSE risk posed by processed animal proteins (PAPs). 
CONCLUSIONS 
From the above examples of recent BIOHAZ opinions it can be seen that the work covers different 
approaches ranging from quantitative risk assessments over structured qualitative risk assessment/risk 
ranking to opinions with short deadlines summarising existence knowledge from scientific literature. 
The approach taken depends on both the ToR as received from the EC, the available data and 
resources and last but not least the timeframe for the work.  
The BIOHAZ Panel has just published two opinions (self-tasking) on experiences and lessons learnt 
from modelling and risk ranking of biological hazards (EFSA Panel on Biological Hazards 
(BIOHAZ), 2012a,b).  
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